Home » Topics » Regulatory » Patents

Patents
RSS

Lilly claims structurally novel NK1 antagonists

Nov. 25, 1996

Mercian discloses novel mitomycin

Nov. 22, 1996

Japanese researchers disclose anti-HIV agents

Nov. 22, 1996

Antitumor lactam isolated by Japanese researchers

Nov. 22, 1996

New carbapenems from Takeda

Nov. 22, 1996

Otsuka describes novel cephems

Nov. 22, 1996

Antidiabetic agents reported by Terumo

Nov. 22, 1996

Antithrombotic/antiallergic agents from Terumo

Nov. 22, 1996

Otsuka discloses inhibitor of TNF-alpha production

Nov. 21, 1996

Anti-H. pylori compounds from Fujisawa

Nov. 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.